本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Anaptysbio Inc

21.77
-0.4500-2.03%
成交量:24.25万
成交额:525.43万
市值:6.68亿
市盈率:-4.25
高:22.24
开:22.14
低:21.22
收:22.22
数据加载中...
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report